FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3211985178> ?p ?o ?g. }

• W3211985178 endingPage "1910" @default.
• W3211985178 startingPage "1910" @default.
• W3211985178 abstract "Abstract Introduction: MGMT is a key enzyme in DNA repair. Epigenetic silencing of the MGMT gene plays a critical role in carcinogenesis and confers increased sensitivity of tumor cells to alkylators. MGMT methylation status is known to be prognostic and predictive of treatment response to Temozolomide in patients with Glioblastoma Multiforme (GBM). Despite advancing knowledge about the clinical implication of MGMT in GBM, there is limited information about the association between tumor MGMT status and hematologic tolerance to Temozolomide. The objective of this study was to evaluate the association of MGMT status and hematologic toxicities after treatment with Temozolomide. Methods: A single institutional retrospective case control study was performed for patients with biopsy proven diagnosis of GBM within the years 2015 to 2020. We collected tumor specific information such as patients MGMT status and treatment specific information including the timing of hematologic adverse events, dose exposure, incidence, and severity of hematologic toxicities. To evaluate the association between tumor MGMT status and hematologic toxicities to Temozolomide we used the Fisher's exact test as well as odds ratio with 95% confidence interval. Results: A total of 74 patients with biopsy proven glioblastoma were evaluated. 44 were MGMT negative while 30 were MGMT positive. All hematologic adverse events occurred within six weeks of exposure to Temozolomide. At the time of the study completion, the number of high grade (grade 3-4) hematologic toxicity events including leukopenia, anemia, thrombocytopenia, or neutropenia were evaluated. There were 2 out of a possible 176 events for nonmethylated MGMT vs 10 out of a possible 120 events for methylated MGMT. This association was determined to be statistically significant with a P value of 0.0051 by Fisher's exact test. Odds ratio (OR) was also calculated with a OR of 7.9, P value of 0.0041 and 95% confidence interval of [1.701- 36.776]. Statistical difference was also noted in the incidence of grade 2-4 thrombocytopenia with 5 events occurring in the methylated group and 0 events occurring in the nonmethylated group with a P value of 0.0088 by Fisher's exact test. Conclusion: Studies have shown the importance of MGMT status in predicting response to treatment with alkylators in patients with GBM. Our study shows that the patients with MGMT methylated GBM tend to develop more hematologic toxicities compared to patients with MGMT non-methylated GBM early in their treatment course, leading to early discontinuation of Temozolomide. This implies these patients need to have close monitoring for hematological toxicity from the initiation of treatment. Further research is warranted to investigate the effect of tumor MGMT status on the DNA repair network in host hematopoietic system after exposure to alkylators. Figure 1 Figure 1. Disclosures No relevant conflicts of interest to declare." @default.
• W3211985178 created "2021-11-22" @default.
• W3211985178 creator A5004924024 @default.
• W3211985178 creator A5066775881 @default.
• W3211985178 creator A5074189344 @default.
• W3211985178 creator A5085219312 @default.
• W3211985178 date "2021-11-05" @default.
• W3211985178 modified "2023-09-28" @default.
• W3211985178 title "Association of O6-Methylguanine Methyltransferase (MGMT) Promotor Methylation Status and the Incidence of Hematologic Toxicities after Treatment with Temozolomide" @default.
• W3211985178 doi "https://doi.org/10.1182/blood-2021-149869" @default.
• W3211985178 hasPublicationYear "2021" @default.
• W3211985178 type Work @default.
• W3211985178 sameAs 3211985178 @default.
• W3211985178 citedByCount "0" @default.
• W3211985178 crossrefType "journal-article" @default.
• W3211985178 hasAuthorship W3211985178A5004924024 @default.
• W3211985178 hasAuthorship W3211985178A5066775881 @default.
• W3211985178 hasAuthorship W3211985178A5074189344 @default.
• W3211985178 hasAuthorship W3211985178A5085219312 @default.
• W3211985178 hasBestOaLocation W32119851781 @default.
• W3211985178 hasConcept C104317684 @default.
• W3211985178 hasConcept C126322002 @default.
• W3211985178 hasConcept C143998085 @default.
• W3211985178 hasConcept C156957248 @default.
• W3211985178 hasConcept C2776694085 @default.
• W3211985178 hasConcept C2777063308 @default.
• W3211985178 hasConcept C2777389519 @default.
• W3211985178 hasConcept C2779527866 @default.
• W3211985178 hasConcept C2780873365 @default.
• W3211985178 hasConcept C33288867 @default.
• W3211985178 hasConcept C55493867 @default.
• W3211985178 hasConcept C71924100 @default.
• W3211985178 hasConcept C86803240 @default.
• W3211985178 hasConcept C91965660 @default.
• W3211985178 hasConceptScore W3211985178C104317684 @default.
• W3211985178 hasConceptScore W3211985178C126322002 @default.
• W3211985178 hasConceptScore W3211985178C143998085 @default.
• W3211985178 hasConceptScore W3211985178C156957248 @default.
• W3211985178 hasConceptScore W3211985178C2776694085 @default.
• W3211985178 hasConceptScore W3211985178C2777063308 @default.
• W3211985178 hasConceptScore W3211985178C2777389519 @default.
• W3211985178 hasConceptScore W3211985178C2779527866 @default.
• W3211985178 hasConceptScore W3211985178C2780873365 @default.
• W3211985178 hasConceptScore W3211985178C33288867 @default.
• W3211985178 hasConceptScore W3211985178C55493867 @default.
• W3211985178 hasConceptScore W3211985178C71924100 @default.
• W3211985178 hasConceptScore W3211985178C86803240 @default.
• W3211985178 hasConceptScore W3211985178C91965660 @default.
• W3211985178 hasIssue "Supplement 1" @default.
• W3211985178 hasLocation W32119851781 @default.
• W3211985178 hasOpenAccess W3211985178 @default.
• W3211985178 hasPrimaryLocation W32119851781 @default.
• W3211985178 hasRelatedWork W1982993379 @default.
• W3211985178 hasRelatedWork W2028367236 @default.
• W3211985178 hasRelatedWork W2155524619 @default.
• W3211985178 hasRelatedWork W2348408917 @default.
• W3211985178 hasRelatedWork W2591716768 @default.
• W3211985178 hasRelatedWork W2767454901 @default.
• W3211985178 hasRelatedWork W2790099097 @default.
• W3211985178 hasRelatedWork W3031744192 @default.
• W3211985178 hasRelatedWork W3158989562 @default.
• W3211985178 hasRelatedWork W3187205508 @default.
• W3211985178 hasVolume "138" @default.
• W3211985178 isParatext "false" @default.
• W3211985178 isRetracted "false" @default.
• W3211985178 magId "3211985178" @default.
• W3211985178 workType "article" @default.